Most Read Articles
6 days ago
Chest pain appears to be the principal complaint of patients hospitalized with a first myocardial infarction (MI), particularly among those in the youngest age group, a study has found.
Jairia Dela Cruz, 16 Sep 2020
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
Pearl Toh, 6 days ago
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Yesterday
Percutaneous coronary intervention (PCI), compared with coronary artery bypass grafting (CABG), in the revascularization of left main coronary artery (LMCA) disease may lead to death, myocardial infarction (MI), or stroke in patients with moderate or severe left ventricular (LV) dysfunction, reveals a study.

Anti-TNFa therapy may increase vitiligo risk

18 Dec 2017

Treatment with antitumor necrosis factor-alpha (anti-TNFa) appears to carry an increased risk of developing vitiligo but not alopecia areata (AA), a study has found.

Drawing data from the Korean National Health Insurance Claims database, researchers examined 11,442 patients with ankylosing spondylitis, Crohn’s disease or ulcerative colitis who received anti-TNFa therapy vs an identical number of matched patients without treatment exposure.

Vitiligo had an incidence rate of 5.9/10,000 person-years in the anti-TNFa group vs 2.5/10,000 person-years in the unexposed group. In multivariable Cox proportional hazards models, there was a significant association between anti-TNFa therapy and the risk of vitiligo (hazard ratio 1.99; 95 percent CI, 1.06 to 3.75). Subgroup analyses revealed that vitiligo risk was greater in younger patients and those treated with etanercept.

On the other hand, the risk of AA was not significantly different between the anti-TNFa and unexposed groups.

“Our results provide insight on the role of cytokine imbalance in the pathogenesis of vitiligo,” researchers said.

The immunogenesis of vitiligo, an acquired immune disorder of the skin characterized by the presence of white depigmented macules, is not completely understood. However, some researchers hypothesized that TNFa plays an important role in vitiligo as it is essential in regulating apoptosis in many cell types including T lymphocytes, and an abnormal expression of TNFa has been observed in patients with the skin condition. [Med Hypotheses 2009;72:546-7]

TNFa suppression is said to be an effective treatment of vitiligo, with topical tacrolimus ointment showing promise as an effective alternative therapy for vitiligo, particularly when the disease involves the head and neck. In a previous study, patients who received treatment showed reduced post-treatment expression of some cytokines, including TNFa, in the depigmented and adjacent uninvolved skin. [J Am Acad Dermatol 2004;51:52–61]

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
6 days ago
Chest pain appears to be the principal complaint of patients hospitalized with a first myocardial infarction (MI), particularly among those in the youngest age group, a study has found.
Jairia Dela Cruz, 16 Sep 2020
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
Pearl Toh, 6 days ago
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Yesterday
Percutaneous coronary intervention (PCI), compared with coronary artery bypass grafting (CABG), in the revascularization of left main coronary artery (LMCA) disease may lead to death, myocardial infarction (MI), or stroke in patients with moderate or severe left ventricular (LV) dysfunction, reveals a study.